gloStream to integrate DiagnosisOne's smartConsult CDS solution into CCHIT-certified EMR offering

DiagnosisOne, the clinical decision support and analytics company, today announced that gloStream has selected DiagnosisOne to provide clinical decision support (CDS) for its electronic medical record (EMR) solutions. Through this relationship, gloStream will seamlessly integrate DiagnosisOne's smartConsult CDS solution into its CCHIT-certified gloEMR offering to deliver real-time, patient-specific alerts at the point of care. The combined offering will address increasing market demand for CDS from gloStream's expanding customer base of Independent Practice Associations (IPAs) and Accountable Care Organizations (ACOs), enabling these organizations to increase care quality, efficiency and accountability.

“Through our partnership with DiagnosisOne, gloStream will combine our powerful, easy-to-use EMR system with real-time, patient-specific clinical decision support at the point of care”

Meaningful Use-certified gloEMR is one of the most powerful and easy-to-use electronic medical record solutions on the market today. Built on the Microsoft® Office platform and backed by a success guarantee, gloEMR features an intuitive dashboard, single-click access to all patient information, Microsoft Word-based templates and integrated voice recognition technology. The company selected DiagnosisOne as the provider of CDS capabilities for its EMR offerings based on the flexibility of DiagnosisOne's standards-based solutions for rapid deployment and their superior ability to deliver patient-specific clinical decision support.

"Through our partnership with DiagnosisOne, gloStream will combine our powerful, easy-to-use EMR system with real-time, patient-specific clinical decision support at the point of care," said Piyush Khanna, gloStream's chief information officer. "We are committed to enhancing productivity and efficiency for doctors and practice staff regardless of practice size or type, and the addition of DiagnosisOne's CDS capabilities will further enable gloStream's customers to focus their valuable time on patient care and improving outcomes."

DiagnosisOne's leading-edge CDS technology enables healthcare providers to efficiently make the most informed, evidence-based treatment decisions. DiagnosisOne provides end-to-end CDS capabilities that automatically make patient information from disparate systems accessible to a provider along with a configurable collection of more than 25,000 actionable clinical observations. DiagnosisOne's standards-based, turnkey solutions are fully configurable to each organization's specific needs with minimal effort.

"As clinical decision support continues to take on increased importance to IPAs, and as providers in growing numbers establish their plans to join ACOs, our partnership with gloStream will help these organizations make the most informed, evidence-based decisions in real time at the point of care," said Dr. Mansoor Khan, founder and CEO of DiagnosisOne. "We look forward to working closely with gloStream to help our mutual customers benefit from increased productivity and continuous quality improvement."

Source:

 DiagnosisOne

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global Alzheimer’s Platform Foundation announces strategic collaboration and partnership with Spear Bio for the transformative Bio-Hermes-002 study